"With this, Bajaj Healthcare aims to provide a safe and effective treatment option for epilepsy patients in India," the ...

PM, Bajaj Healthcare share price was up 6.2 per cent at Rs 715.6 per share on BSE. In comparison, the BSE Sensex was up 0.3 ...

Epilepsy patients and advocates are calling on the Saskatchewan government to provide public coverage for a new anti-seizure drug. Xcopri, the brand name for cenobamate tablets, is a medication ...